Purpose: Depression is indicative of poor prognosis in cardiac patients. Reductions in depression have been observed following cardiac rehabilitation (CR). Whether similar improvements in positive and negative affect occur is unknown. Greater understanding of depressive symptom and affect change is needed to enhance facilitators of emotional improvement after a cardiac event.
C
ardiac rehabilitation (CR) leads to improvements in morbidity and mortality, 1 , 2 likely through improvements in modifi able risk factors. Importantly, the American Heart Association recognizes depression as a relevant risk factor in acute coronary syndrome due to the demonstrated relationship between depression and prognosis. 3 Approximately 15% to 45% of individuals with cardiovascular disease exhibit depressive symptoms or clinical depression. 4 , 5 Prior research has established that depression improves following CR, 6 though continued depression at discharge remains predictive of increased mortality risk. 7 Less is known about whether other aspects of psychological functioning, such as positive and negative affect, are similarly impacted by CR. Positive and negative affect represent distinct constructs, evidenced most prominently by different patterns of neurological activation. [8] [9] [10] For example, left hemisphere impairment has been associated with negative emotions such as crying, whereas right hemisphere impairment was related to positive mood states such as laughing. Negative affect includes a broader range of negative emotions (ie, fear, hostility) than are included in the depression criteria, but excludes the vegetative or cognitive components of depression. In addition, positive affect (eg, joy, happiness, alertness) refl ects mood states that are not part of depression diagnostic criteria or that function as mere opposites of aspects of negative affect.
Cardiac rehabilitation may contribute to increased positive affect in multiple ways. Higher positive affect corresponds with exercise frequency in individuals with ischemic heart disease, and exercise has been shown to mediate the relationship between positive affect and survival. 11 Also, affect may improve as a result of psychoeducational lectures or social support provided by CR.
In addition to the impact of CR on affect, predictors of depression and affect change are not fully understood. Increased exercise capacity has been observed alongside improvement in depressive symptoms post-CR. 6 However, others reported no relationship between depression improvement and changes in exercise capacity or body mass index (BMI) in CR. 12 Regarding positive affect, increased positive affect over 5 y was recently linked to increased physical activity, sleep quality, and medication adherence in ischemic heart disease. 13 Given evidence that positive affect is pertinent to health behavior engagement and improved long-term outcomes, understanding whether affect improves over the course of CR and is associated with other functional changes may extend understanding of the psychosocial and behavioral benefi ts of CR.
Examination of predictors of depressive symptom and affect change may provide insight into potential intervention targets to maximize the effect of CR on psychosocial functioning. Thus, the current study sought to examine changes in depressive symptoms and affect following CR completion in a large clinical cohort, as well as identify (1) baseline variables predictive of depressive symptom and affect improvement and (2) candidate mechanisms that may facilitate depressive symptom and affect improvement. Working from a biopsychosocial framework, we hypothesized that (1) depressive symptoms and affect would improve from baseline to discharge; (2) baseline poor mood (ie, high depressive symptoms, low positive affect, and high negative affect) would predict larger improvements in that mood variable at discharge; and (3) improvements in social support and self-reported and objective indices of physical functioning would predict concurrent improvement in depressive symptoms and affect.
METHODS

PARTICIPANTS
Participants were enrollees in a comprehensive CR program in Providence, Rhode Island, between October 1, 2014, and June 27, 2016, who completed ≥ 18 sessions (n = 650). We excluded patients with the uncommon CR indications: cardiac transplant (n = 2), percutaneous valve implantation (n = 3), and ventricular assist device/artifi cial heart (n = 1), and those with no diagnosis listed (n = 7) for a sample of 637 (patients with admission diagnoses of angina, coronary artery bypass graft surgery, heart failure, non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, valve repair/replacement, and percutaneous coronary intervention).
MEASURES
Demographic, psychosocial, and medical information was collected through the CR program following published guidelines.
14 Clinical outcomes including systolic and diastolic blood pressure (BP) and BMI were collected by CR staff during intake and discharge visits. Metabolic equivalents (METs) were estimated from a treadmill exercise test at baseline and discharge. In addition, patients completed the following psychosocial self-report measures during intake and discharge.
Patient Health Questionnaire-9
The Patient Health Questionnaire-9 (PHQ-9) 15 , 16 is a 9-item depression screening measure. Scores < 5 indicate no to minimal depressive symptoms, scores from 5 to 9 represent mild depression, and scores from 10 to 14 suggest moderate depression. Scores from 15 to 19 are moderately severe depressive symptoms and scores from 20 to 27 refl ect severe depressive symptoms.
Positive and Negative Affect Schedule
The Positive and Negative Affect Schedule (PANAS) 17 is a 20-item questionnaire that asks individuals to rate their experience of 20 emotions during the past week on a 5-point Likert scale. Two subscales are created, with 10 items refl ecting positive affect and 10 refl ecting negative affect. Subscale scores range from 10 to 50, with higher scores indicating higher affect. Although specifi c cutoffs do not exist for the PANAS, a large examination of a nonclinical sample indicated a mean of 31.31 ± 7.65 for positive and 16 ± 5.90 for negative affect. 18 
ENRICHD Social Support Instrument
The ENRICHD Social Support Instrument (ESSI) 19 , 20 is a 7-item questionnaire that measures social support. Higher total scores refl ect higher social support.
Rand 36-Item Short Form Survey
The Rand 36-Item Short Form Survey (Rand-36) 21 is a 36-item questionnaire that assesses 8 health-related concepts. Higher scores denote higher functioning. For the current study, we reported the results of all subscales but included in regression analyses only subscales that ask about specifi c physical abilities (Physical Functioning Scale), physiological experiences (Pain Scale, Vitality Scale), or problems that are specifi cally stated as due to physical health (Physical Role Functioning Scale). We avoided subscales that represent conceptual overlaps with our primary outcome variables related to mood such as those asking about mental health symptom severity (Emotional Well-being Scale), problems that are specifi cally stated as due to mental health symptoms (Emotional Role Functioning Scale), problems due to mental or physical health (Social Functioning Scale), and ratings of general health that do not specify whether patient is rating mental and/or physical health (General Health Scale).
PROCEDURES
Upon enrollment, patients completed an intake assessment that included review of demographic and medical history, completion of psychosocial questionnaires, and functional assessment. Staff entered demographic and medical history and patients completed self-report questionnaires using a patient portal. Patients are typically recommended to complete 36 total sessions or 3 sessions/wk for 12 wk. However, because of insurance reimbursement differences, some patients completed planned discharges from the program before reaching 36 sessions but no earlier than 18 sessions. Thus, for the current study, "CR completion" was defi ned as completion of ≥ 18 sessions. In the program, patients are followed by a registered nurse, exercise physiologist, or physical therapist as case managers under the supervision of a cardiologist, and patients can meet individually with a dietician, pharmacist, and/or clinical psychologist as needed. Cardiac rehabilitation sessions consisted of monitored exercise training and educational lectures on topics including cardiovascular conditioning and behavior modifi cation aimed at secondary prevention. At exit, patients completed a discharge assessment that included completion of psychosocial questionnaires.
STATISTICAL ANALYSIS
Descriptive statistics were calculated to provide sample characteristics. Paired t tests were used to examine mean differences between intake and discharge psychosocial and physical functioning measures.
Hierarchical multiple linear regressions (ie, stepped regression models) were used to examine predictors of discharge depressive symptoms and affect while controlling for baseline depressive symptoms and affect. First, stepped regression models were conducted in order to select baseline demographic/medical covariates to be included in subsequent analyses. The following were examined: age, sex, minority status (minority vs non-Hispanic white ), and intake tobacco use status (never/former smoker vs current smoker). The presence of the following comorbidities was also examined: diabetes, renal disease, pulmonary disease, cerebrovascular disease, cancer, and peripheral artery disease. For each of the 3 outcomes (ie, discharge PHQ-9 score, positive affect, and negative affect), all baseline demographic/ medical variables were examined in a separate hierarchical regression model where step 1 included the intake outcome score (ie, PHQ-9 score, positive affect, or negative affect). Step 2 included the baseline demographic/medical variable entered alone. Any predictors that explained ≥ 1% of the variance (ie, corresponding to a small effect size, R 2 change > .01) in discharge depressive symptoms/affect after controlling for intake depressive symptoms/affect were included as covariates in fi nal multivariable models.
Second, several stepped regression models were performed to identify important predictors of depressive symptom and affect improvement. Change ( Δ ) scores were created by calculating the difference between the intake and discharge scores. Change scores were calculated for the ESSI (social support), Rand-36 physical functioning, Rand-36 role limitations due to physical health, Rand-36 vitality, Rand-36 bodily pain, BMI, systolic and diastolic BP, and METs. For each of the 3 outcomes, Δ scores were entered into step 2 of a linear regression predicting discharge depressive symptoms and affect.
Step 1 included intake depressive symptoms/affect and any baseline variables that met the above criteria to be included as covariates. Any Δ scores that explained at least 1% of the variance in discharge depressive symptoms or affect after controlling for the respective intake score were included in fi nal multivariable models.
Finally, a multivariable regression model was used to determine independence of prediction. All Δ scores that predicted at least 1% of the variance in discharge depressive symptoms or affect were entered simultaneously into step 2 of a parallel hierarchal model to determine independence of prediction, with baseline scores and covariates included in step 1. For the multivariable analyses, patients missing data for any variables of interest were excluded from the analysis. The Statistical Package for the Social Sciences (IBM, SPSS) version 20.0 statistical software was used for analyses.
RESULTS
SAMPLE CHARACTERISTICS
The sample was primarily male (73.0%) and non-Hispanic white (94.3%), with an average age of 63.63 ± 11.32 y. The majority (77.10%) was married and/or living with a partner. Approximately 34% of the sample reported at least mild depressive symptoms (PHQ-9 ≥ 5). The mode number of sessions completed was 36 (n = 231, 36.3%). Additional sample characteristics are presented in Table 1 . Changes in depressive symptoms, affect, physical functioning, and social support are reported in Table 2 .
DEPRESSIVE SYMPTOMS
Depressive symptoms improved an average of 1.64 ± 3.15 points following treatment ( P < .001, d = 0.40). Baseline intake PHQ-9 scores explained 43.8% of the variability in discharge PHQ-9 scores ( P < .001), with higher intake scores predicting higher discharge scores ( β = .66, P < .001). Minority status (ie, minority vs non-Hispanic white) was also related to discharge PHQ-9 scores after controlling for intake PHQ-9 scores ( Δ R 2 = 0.014), with minority individuals demonstrating higher discharge PHQ-9 scores than nonminority individuals (mean difference post-treatment = 2.07 [standard error = 0.87], P < .05). When examined separately after controlling for intake PHQ-9 scores and minority status, predictors of lower PHQ-9 scores at discharge included increases in Rand-36 Vitality ( Δ R 2 = 0.095), Rand-36 Physical Functioning ( Δ R 2 = 0.031), Rand-36 Pain ( Δ R 2 = 0.028), and Rand-36 Physical Role Functioning ( Δ R 2 = 0.028; Table 3 ), all P values < .01. When entered into multivariable analyses together, after controlling for intake PHQ-9 score and minority status, the linear combination of variables explained an additional 10.3% of the variance in discharge PHQ-9 scores ( P < .001). The strongest predictor of a decrease in PHQ-9 scores was improvement in Rand-36 Vitality ( β = − .254), followed by improvement in Rand-36 Bodily Pain ( β = − .081; Table 4 ).
As a post hoc analysis, we further examined improvements in depressive symptoms for minority and nonminority individuals. Nonminority participants reported an average of 1.72 ± 3.12 (from 4.07 at intake to 2.35 at discharge) point reduction in depressive symptoms ( P < .001). Minority individuals reported an average of 0.23 ± 3.34 (from 4.57 at intake to 4.43 at discharge) point reduction in depressive symptoms ( P = .692). 001, d = 0.26) . Intake negative affect explained 38.1% of the variance in discharge negative affect ( P < .001). Higher negative affect at the time of intake predicted higher negative affect at discharge ( β = .62, P < .001). Next, predictors of change in negative affect were examined separately ( Table 3 ) . Predictors of lower negative affect at discharge included improvement in Rand-36 Vitality ( Δ R 2 = 0.063), ESSI ( Δ R 2 = 0.014), Rand-36 Physical Role Functioning ( Δ R 2 = 0.015), and Rand-36 Physical Functioning ( Δ R 2 = 0.015). When entered into multivariable analyses, the combination of variables accounted for an additional 7.6% of the variance in discharge negative affect beyond intake negative affect ( P < .001). The strongest predictors of a reduction in negative affect were improvements in Rand-36 Vitality ( β = − .23) and ESSI ( β = − .11; Table 4 ). 
NEGATIVE AFFECT
Negative affect decreased an average of 1.52 ± 4.77 points following CR ( P < .
POSITIVE AFFECT
Positive affect increased an average of 2.61 ± 7.07 points following CR ( P < .001, d = 0.34). Intake positive affect explained 59.5% of the variability in discharge positive affect ( P < .001). Higher intake positive affect predicted higher discharge positive affect ( β = .66, P < .001). When examined individually, predictors of higher discharge positive affect included improvements in Rand-36 Vitality ( Δ R 2 = .097), ESSI ( Δ R 2 = 0.030), Rand-36 Physical Role Functioning ( Δ R 2 = 0.04), and Rand-36 Physical Functioning ( Δ R 2 = 0.031). In multivariable analysis, the combination of variables explained an additional 13.6% of variance in discharge positive affect ( P < .001). The strongest predictors of higher discharge positive affect were increases in Rand-36 Vitality ( β = .25), followed by increases in ESSI ( β = .16).
Changes in objective indicators of physical health (METs, BMI, and BP) were not signifi cantly associated with depressive symptoms or affect change in any analysis ( Tables 3 and 4 ).
DISCUSSION
The current study examined changes in depressive symptoms and affect in CR completers, and improvements in both depressive symptoms and affect were observed. Independent, multivariable predictors of depressive symptom improvement included increased vitality and decreased bodily pain. Multivariable predictors of positive affect were social support, vitality, and physical role functioning. Multivariable predictors of negative affect were vitality and social support.
Consistent with prior work, a signifi cant small to moderate effect on depressive symptoms was observed. Approximately 34% of the sample reported at least mild symptoms at intake, whereas approximately 19% did at discharge. Symptoms of depression are a potential barrier to health behavior change 22 and specifi cally within CR setting, 23 so even a small change in symptomology may result in greater engagement in preventive behaviors, such as CR attendance and engagement. In addition, small reductions are clinically signifi cant as even mild symptoms of depression are associated with increased mortality risk. 24 The current fi ndings showed small to moderate improvements in positive and negative affect during CR. To our knowledge, this is the fi rst study to demonstrate that positive affect improves following CR. Increased positive affect is also likely to be clinically meaningful, given prior work linking low positive affect to increased mortality risk.
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Increased vitality was most strongly and consistently predictive of depressive symptom and affect improvement. Items of the vitality subscale assessed subjective feelings of "pep," energy, and fatigue. Prior meta-analytic work revealed moderately large increases in energy and reductions in fatigue following exercise-based CR. 25 Some have suggested that energy refl ects feeling as though one is mentally or physically able to complete activities. 25 , 26 However, more work is needed to understand the importance of increased vitality and improvements in depressive symptoms and affect.
Social support remained stable for the overall sample. Nonetheless, improvements in social support were associated with improved positive affect and reduced negative affect. Higher social connectivity is related to higher positive affect, 27 potentially due to increased availability of instrumental, informational, and emotional support. For individuals with low social support upon program entry, CR may facilitate increased social support through staff involvement or interaction with other attendees. As a result, attendees learn skills to navigate barriers to disease management, while also having the opportunity to interact with and emotionally support other patients. These opportunities may lead to increases in positive emotionality.
In multivariable analyses, smaller relationships emerged between improved physical role functioning and positive affect and between bodily pain and depressive symptoms. Individuals may report higher positive affect upon experiencing an increased ability to engage in their typical activities. It is feasible that engaging in repeated exercise signifi cantly decreases pain experienced during daily life activities, which may decrease activity restriction and depression. [28] [29] [30] However, as changes in physical role functioning and bodily pain were neither strongly nor consistently predictive across the different outcomes, replication of the current fi ndings is needed.
Surprisingly, improvements in depressive symptoms and affect were unrelated to changes in objective indicators of physical health. However, the extant literature is mixed, with some reporting no relationship between changes in depressive symptoms and BMI or exercise capacity. 6 , 12 Stronger effects may be apparent in individuals with higher depressive symptoms and negative affect or lower positive affect.
Limitations of the present study warrant mention. First, the sample was largely homogenous and may not generalize to samples with more women or minority participants. Second, engagement in psychiatric treatment concurrent with CR was not assessed. Third, the causality of the relationships among variables of interest warrants further study. Fourth, the present study included a heterogeneous group of cardiac patients. Future studies may consider testing the current fi ndings in more targeted cardiac populations, and include cardiac-focused assessments, to determine whether the current fi ndings apply similarly across cardiac samples. In addition, inclusion of cardiac-specifi c metrics may allow for further examination of the contribution of improved cardiac health to improvements in mood. Finally, unmeasured physiological mechanisms, such as reduced infl ammation or other psychosocial factors (ie, increased self-effi cacy), may have also contributed to depressive symptom and affect change.
Nonetheless, this study demonstrated that depressive symptoms and affect improve following CR completion. To our knowledge, this study represents the fi rst evidence of the positive affect-related benefi ts of CR. Concomitant improvements in vitality, social support, and bodily pain suggest that they may be mechanisms of depressive symptom and affect improvement. Future investigators and practitioners are encouraged to incorporate consideration of the interaction of psychosocial factors and physical outcomes when designing and implementing interventions targeting cardiac patients.
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